Fundraising FoxBisc Therapeutics
1 known investors
Find your way into Bisc Therapeutics
Sign up to see every warm intro you have to Bisc Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bisc Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders. The company operates in the biotech/ophthalmology therapeutics space.
Investors · 1
Frequently asked questions
- What does Bisc Therapeutics do?
- Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders. The company operates in the biotech/ophthalmology therapeutics space.
- Who are Bisc Therapeutics's investors?
- Bisc Therapeutics's investors include CWRU Technology Ventures.